Using Collaborative Care to Treat Patients with Cancer
Steve Adubato speaks with Barry Ostrowsky, President & CEO, RWJBarnabas Health, and Steven K. Libutti, MD, FACS, Senior Vice President, Oncology Services, RWJBarnabas Health, and Director, Rutgers Cancer Institute of New Jersey, about the new Cancer Pavilion and how collaborative care increases survivorship in cancer patients.
"This is one on one (music playing)We are pleased to welcome first Barry Ostrowsky, president CEO RWJ Barnabas health and dr. Steven Libutti senior vice president oncology services RWJ Barnabas health and director the Rutgers cancer institute of new jersey thank you gentlemen for joining us .thanks for having us, Steve. .Barry put this in context why is this initiative why is this relationship so important when it comes to cancer care? Well our relationship with Rutgers university and the medical schools are critical we think for the health of the communities we serve in the state of new jersey as to cancer the cancer institute the Rutgers cancer institute of new jersey is among only 50 in the united states with the national Designation does incredible research, offers incredible clinical possibilities to the people who live in new jersey it's our job as RWJ Barnabas health to support those initiatives for the betterment of our communities we couldn't be happier and of course Steve is a fabulous leader and a great clinician and we're doing academics and research and clinical care this is why we're in business. Let me do this before you jump back in, doctors to make it clear those of you who watch us you know that RWJ Barnabas health is not just a major funder of public broadcasting in our production as well but Barry serves on the board of NJ TV, let me ask you doctor I just asked you before we got on the air, cancer care last five years, biggest changes are? Technology so we understand that cancer is often a disease of genes and our ability to look and sequence genes and Individual cancers so called precision medicine has really allowed us to make tremendous advances and immunotherapy harnessing the body's own immune system. Break that down immunotherapy .in laypersons language is? So immunotherapy essentially is stimulating your body's own immune system to fight against cancer and it's been around for a while but over the last five to ten years has really begin to make begun to make tremendous progress on our ability to apply it to patients for successful treatments for cancer and so it's essentially your own body's immune cells become the warriors against your tumor. You know it's interesting Barry, you and I talk about leadership a lot right and I’ve done some leadership coaching at your place as well but technology it's interesting the connection between innovation or technology than innovation and it's tied a leadership in this field am I making too much of that? Not at all and you are an expert on leadership Steve and so here what you have is the need for leadership that's able to..."